** Shares of medical product maker Bioventus BVS.O soar 23.5% to $10.82
** Q4 total revenue rises 13.5% to $153.6 million from a year ago, beating analysts' estimate of $145.2 million - data compiled by LSEG
** Co reports quarterly adjusted EPS of 15 cents per share vs estimate of 8 cents per share
** Including session's move, stock is up 1.4% YTD
(Reporting by Jaiveer Singh Shekhawat in Bengaluru)
((JaiveerSingh.Shekhawat@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.